Cancers, Vol. 13, Pages 5183: Particle Beam Therapy Tolerance and Outcome on Patients with Autoimmune Diseases: A Single Institution Matched Case –Control Study

CONCLUSIONS. G3 acute toxicity was more frequently reported in AD patients after PT or CIRT. Since no severe G4–G5 events were reported and in consideration of the benefit of particle therapy for selected cancers, we conclude that particle therapy should be not discouraged for patients with ADs. Further prospective studies are warranted to gain insight into toxicity in cancer patients with ADs enrolled for particle therapy.

Source: Cancers - October 15, 2021 Category: Cancer & Oncology Authors: Giulia Riva Barbara Vischioni Sara Gandini Stefano Cavalieri Sara Ronchi Amelia Barcellini Maria Bonora Agnieszka Chalaszczyk Rossana Ingargiola Viviana Vitolo Maria Rosaria Fiore Alberto Iannalfi Ester Orlandi Tags: Article Source Type: research